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Comparisons of in-house wheat skin prick test extracts for the diagnosis of wheat dependent exercise induced anaphylaxis (WDEIA) Siwaporn Sapsaprang, MD, Thunyatorn Phisitbuntoon, MD, Punchama Pacharn, MD, Witchaya Srisuwatchari, MD, Nualanong Visitsunthorn, MD, and Orathai Jirapongsananuruk, MD; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand. RATIONALE: Skin prick test (SPT) and specific IgE (sIgE) to wheat help diagnose wheat dependent, exercise-induced anaphylaxis (WDEIA) in addition to food and exercise challenges. However, commercial wheat extract and sIgE to wheat provide unsatisfactory results. We determined the performance of in-house wheat extracts for SPT and compared them with commercial extract as well as sIgE to wheat and v5-gliadin, for the diagnosis of WDEIA. METHODS: Nine patients with WDEIA and 9 controls with history of wheat allergy and negative wheat challenges, were recruited. SPT using 4 in-house extracts (wheat Coca's, wheat sodium base (SB), gliadin and glutenin solutions), and commercial extract, were performed. SIgE to wheat and v5-gliadin were measured. RESULTS: Patients with WDEIA were significantly older (15.3 vs 5.3 years, p50.01) and had later onset of symptoms compared to controls (5.5 vs 0.6 years, p50.001). The mean wheal diameter of SPT of all, except commercial extract, were significantly larger in WDEIA compared to controls (p<0.05). SIgE to v5-gliadin, but not to wheat, was significantly higher in WDEIA compared to controls (p50.0001). Using their best cutoffs by the ROC curve, the sensitivities of in-house wheat-Coca's, SB, gliadin, glutenin, and commercial extracts, sIgE for wheat and v5-gliadin were 77.8%, 66.7%, 88.9%, 77.8%, 44.4%, 77.8% and 88.9%, respectively. The specificities were 66.7%, 77.8%, 88.9%, 88.9, 88.9%, 66.7% and 100%, respectively. SIgE to v5-gliadin provided the best positive and negative likelihood ratio (+LR5a, -LR50.11) followed by SPT to gliadin (+LR58, -LR50.12). CONCLUSIONS: SIgE to v5-gliadin and SPT with gliadin extract were useful tools in diagnosing WDEIA. We retrospectively reviewed outcomes of OFC in a single center over 10 months. Analysis included all children aged less than 1.5 years who underwent OFC based on clinician assessment of history and testing. Failure was defined as any objective symptom requiring either cessation of feeding and/or treatment. RESULTS: Of 60 infant food challenges (median age 11 months, IQR 9-12), there were 20 failures (33%), including 9 peanut, 5 baked egg, 2 cow milk, 2 tree nut, 1 unbaked egg, and 1 wheat. Symptoms among those failing were most often cutaneous (80%, N516) and gastrointestinal (35%, N57). Two (10%) developed cough; none had respiratory distress. Of failures, 30% (N56) were given epinephrine; 4 for urticaria with emesis, and 2 for diffuse urticaria. Median skin prick test (SPT) wheal diameter for failures was 7 mm (IQR 3-8); for passes, 3 mm (IQR 2-4). Of 23 challenges for peanut, 39% (N5 9) were failures; median SPT wheal for peanut failures was 6.5mm (IQR 4-8); for passes, 2 mm (IQR 0-3.5). No infant with peanut SPT <2 mm failed. CONCLUSIONS: Infant OFC may be safely conducted in the office. Need for intervention with epinephrine in 10% of OFC (30% of failures) suggests a benefit of screening and in-office challenges. Introduction of peanut at home for infants with SPT diameter less than 2mm appears to be safe.
